Market Overview:
The global hypermetropia treatment market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of hypermetropia, technological advancements in the field of ophthalmology, and rising awareness about eye health. The global hypermetropia treatment market is segmented on the basis of type into surgery treatment and lens correction. The surgery treatment segment is further sub-segmented into laser refractive surgery and corneal transplantation. The lens correction segment is further sub-segmented into contact lenses and eyeglasses/spectacles. On the basis of application, the market is divided into hospitals, specialty centers, diagnostic centers, clinics, and others (including research institutes and academic institutions). Geographically, the global hypermetropia treatment market is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U.K.), Asia Pacific (China Japan India Australia South Korea) Middle East & Africa(GCC Countries Turkey Nigeria South Africa).
Product Definition:
Hypermetropia Treatment is the use of glasses, contact lenses, or surgery to correct vision in people with hypermetropia.
Surgery Treatment:
The global surgery treatment, it's usage and growth factor in hypermetropia treatment market size was valued at USD 1.1 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of myopia globally along with rising awareness about its management is expected to drive the market growth over the forecast period.
Lens Correction:
Lens correction is a surgical procedure that changes the shape of the cornea to improve visual acuity. The most common procedures performed on patients with hypermetropia are keratoplasty and glaucoma surgery. Hypermetropia usually results from an abnormal growth of the eye (corneal abrasion or trauma, genetic mutation, inflammation or infection) and can be treated by reshaping either the cornea or lens.
Application Insights:
Based on application, the global hypermetropia treatment market is segmented into hospitals, specialty centers, diagnostic centers, clinics and others. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities at a large scale. Moreover, hospitals are considered as one of the most prominent places for medical diagnosis due to high number of patients presenting with similar symptoms every year. This factor is anticipated to fuel growth over next few years.
The specialty centers are expected to witness lucrative CAGR during forecast period owing to increasing number of patients seeking vision correction procedures after undergoing LASIK surgery at these facilities.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing cases of myopia and hypermetropia, rising healthcare expenditure, technological advancements in metrology devices, and high adoption of advanced treatment procedures. In addition, presence of key players such as Alcon; Novartis AG; Bausch & Lomb Inc.; Cylance Inc.; and IKAROS Surgical Corp., has contributed to the growth of this regional market.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as growing population with vision-related disorders coupled with increasing awareness about various treatment options available for these conditions along with rising disposable income levels in emerging countries like China & India are anticipated to drive this regional market at a significant pace during the forecast period from 2018 To 2030 (USD X billion).
Growth Factors:
- Increasing prevalence of hypermetropia
- Growing awareness about the benefits of hypermetropia treatment
- Technological advancements in the field of hypermetropia treatment
- Rising demand for minimally invasive procedures for hypermetropia treatment
- increasing number of ophthalmologists and optometrists
Scope Of The Report
Report Attributes
Report Details
Report Title
Hypermetropia Treatment Market Research Report
By Type
Surgery Treatment, Lens Correction
By Application
Hospitals, Specialty Centers, Diagnostic Centers, Clinics, Others
By Companies
Allergan plc, Abbott Laboratories Inc., ALCON VISION LLC, Bausch + Lomb Incorporated, Carl Zeiss Inc., Essilor Ltd., Haag-Streit UK, Johnson & Johnson Vision, Lasersight Technologies Inc., Nidek Co. Ltd., ORASIS Pharmaceuticals Ltd., Topcon Corporation, Visioneering Technologies, Inc., Ziemer Ophthalmic Systems AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Hypermetropia Treatment Market Report Segments:
The global Hypermetropia Treatment market is segmented on the basis of:
Types
Surgery Treatment, Lens Correction
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Centers, Diagnostic Centers, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan plc
- Abbott Laboratories Inc.
- ALCON VISION LLC
- Bausch + Lomb Incorporated
- Carl Zeiss Inc.
- Essilor Ltd.
- Haag-Streit UK
- Johnson & Johnson Vision
- Lasersight Technologies Inc.
- Nidek Co. Ltd.
- ORASIS Pharmaceuticals Ltd.
- Topcon Corporation
- Visioneering Technologies, Inc.
- Ziemer Ophthalmic Systems AG
Highlights of The Hypermetropia Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgery Treatment
- Lens Correction
- By Application:
- Hospitals
- Specialty Centers
- Diagnostic Centers
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hypermetropia Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hypermetropia is a condition in which the eyes are too far apart. This can cause difficulty seeing things close up and distant objects to be blurry. Treatment for hypermetropia typically includes wearing eyeglasses or contact lenses, depending on the severity of the condition.
Some of the major companies in the hypermetropia treatment market are Allergan plc, Abbott Laboratories Inc., ALCON VISION LLC, Bausch + Lomb Incorporated, Carl Zeiss Inc., Essilor Ltd., Haag-Streit UK, Johnson & Johnson Vision, Lasersight Technologies Inc., Nidek Co. Ltd., ORASIS Pharmaceuticals Ltd., Topcon Corporation, Visioneering Technologies, Inc., Ziemer Ophthalmic Systems AG.
The hypermetropia treatment market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hypermetropia Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hypermetropia Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hypermetropia Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hypermetropia Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hypermetropia Treatment Market Size & Forecast, 2018-2028
4.5.1 Hypermetropia Treatment Market Size and Y-o-Y Growth
4.5.2 Hypermetropia Treatment Market Absolute $ Opportunity
Chapter 5 Global Hypermetropia Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hypermetropia Treatment Market Size Forecast by Type
5.2.1 Surgery Treatment
5.2.2 Lens Correction
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hypermetropia Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hypermetropia Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Centers
6.2.3 Diagnostic Centers
6.2.4 Clinics
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hypermetropia Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hypermetropia Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hypermetropia Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Hypermetropia Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hypermetropia Treatment Market Size Forecast by Type
9.6.1 Surgery Treatment
9.6.2 Lens Correction
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hypermetropia Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Centers
9.10.3 Diagnostic Centers
9.10.4 Clinics
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hypermetropia Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Hypermetropia Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hypermetropia Treatment Market Size Forecast by Type
10.6.1 Surgery Treatment
10.6.2 Lens Correction
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hypermetropia Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Centers
10.10.3 Diagnostic Centers
10.10.4 Clinics
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hypermetropia Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hypermetropia Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hypermetropia Treatment Market Size Forecast by Type
11.6.1 Surgery Treatment
11.6.2 Lens Correction
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hypermetropia Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Centers
11.10.3 Diagnostic Centers
11.10.4 Clinics
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hypermetropia Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Hypermetropia Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hypermetropia Treatment Market Size Forecast by Type
12.6.1 Surgery Treatment
12.6.2 Lens Correction
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hypermetropia Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Centers
12.10.3 Diagnostic Centers
12.10.4 Clinics
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hypermetropia Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hypermetropia Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hypermetropia Treatment Market Size Forecast by Type
13.6.1 Surgery Treatment
13.6.2 Lens Correction
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hypermetropia Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Centers
13.10.3 Diagnostic Centers
13.10.4 Clinics
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hypermetropia Treatment Market: Competitive Dashboard
14.2 Global Hypermetropia Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan plc
14.3.2 Abbott Laboratories Inc.
14.3.3 ALCON VISION LLC
14.3.4 Bausch + Lomb Incorporated
14.3.5 Carl Zeiss Inc.
14.3.6 Essilor Ltd.
14.3.7 Haag-Streit UK
14.3.8 Johnson & Johnson Vision
14.3.9 Lasersight Technologies Inc.
14.3.10 Nidek Co. Ltd.
14.3.11 ORASIS Pharmaceuticals Ltd.
14.3.12 Topcon Corporation
14.3.13 Visioneering Technologies, Inc.
14.3.14 Ziemer Ophthalmic Systems AG
